Korean Circ J.  2021 Aug;51(8):708-709. 10.4070/kcj.2021.0229.

“Obesity and Lean Paradox” in Peripheral Artery Disease

• Lee SH
• Kim JH

• KMID: 2519152
• DOI: http://doi.org/10.4070/kcj.2021.0229

Reference

1. Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018; 3:280–287. PMID: 29490333.

2. Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018; 61:142–150. PMID: 29981771.

3. Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021; 143:e984–1010. PMID: 33882682.

4. Golledge J, Cronin O, Iyer V, Bradshaw B, Moxon JV, Cunningham MA. Body mass index is inversely associated with mortality in patients with peripheral vascular disease. Atherosclerosis. 2013; 229:549–555. PMID: 23742964.

5. Murata N, Soga Y, Iida O, et al. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment. Eur J Vasc Endovasc Surg. 2015; 49:297–305. PMID: 25524520.

6. Lim C, Won H, Ko YG, et al. Association between body mass index and clinical outcomes of peripheral artery disease after endovascular therapy: data from K-VIS ELLA registry. Korean Circ J. 2021; 51:696–707. PMID: 34327883.

7. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000; 894:i–ixii. 1–253. PMID: 11234459.

8. Lee SH, Jeong MH, Kim JH, et al. Influence of obesity and metabolic syndrome on clinical outcomes of ST-segment elevation myocardial infarction in men undergoing primary percutaneous coronary intervention. J Cardiol. 2018; 72:328–334. PMID: 29709405.